Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

STENOCARE

Ylin-
Alin-
Vaihto-
2026 Q1 -tulosraportti

Vain PDF

68 päivää sitten

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
7.5.
2025 Q4 -tulosraportti
26.2.
2025 Q3 -tulosraportti
22.10.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 3 päivää sitten
    ·
    Buying up again today
  • 10.7.
    ·
    I only discovered this today. Weeco Pharma has been at the EU's largest cannabis fair for professionals such as pharmacists and dealers. Weeco Astrum10-10 was part of their campaign already at the fair, which may be the reason why it has been possible for Weeco Pharma that so many doctors, in such a short time, have become aware of the oil. https://weeco.com/en/2026/02/13/weeco-will-be-present-at-the-icbc-in-berlin-on-april-13th-and-15th/
    19 t sitten
    ·
    It's also nothing new that there is risk in investing in stocks, and that applies to all stocks, there are no safe stocks, see what has happened with Novo Nordisk, just to give an example of a stock that was considered a safe investment. The only thing I am impatient about is to find out how much Stenocare has earned in Q2, in Germany. Tomorrow it will be 14 days since Q2 closed, and since both pharmacies and the various distributors have been digitized in Germany, Weeco Pharma must soon have finished calculating what Stenocare has earned in Germany. Regardless of the amount's size, it is much more than TS and PJ have announced, since they have stated that there will be 0 kr. in earnings from Germany in 2026.
  • 6.7.
    ·
    A little statistics while we wait for Weeco to get signed with Stenocare. In 2025, more than 6,900 liters of cannabis oils and extracts were sold, and it is expected that this will be increasing in 2026. When I have this converted to 30 ml bottles, with the help of AI, it amounts to 230,000 bottles in 2025. Bearing in mind that the subsidy is taken from flowers and vaporizers, https://www.insight-health.de/deu_en/our-solututions/specialty-therapeutics/medical-cannabis.html
    9.7.
    Ok
  • 6.7.
    ·
    This is falling and falling, it's certainly a hopeless case.
    9.7.
    ·
    10 k in turnover today, is it a sinking ship? Is it just a matter of getting out before the ship sinks?
  • 3.7.
    ·
    STENOCARE completes the integration of CannGros ApS Fri, 3. July 2026 19:37 CETReport this content STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DANMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) is pleased to announce that the integration of CannGros ApS, which was acquired in November 2025, has now been successfully completed by the end of June 2026. The integration of CannGros ApS has been completed as planned with several successful import, repackaging and sales processes, the company merger concluded and process optimizations implemented to reduce both costs and delivery time. https://news.cision.com/stenocare/r/stenocare-completes-integration-of-canngros-aps,c4371090
    5.7. · Muokattu
    ·
    I'm not thinking that far ahead with this stock. I take one quarter at a time..management expects 0 kr. in sales from Germany for the entire 2026. See previous link. There will be revenue from Germany, the question is how much, and if it turns out that management can see that they will exceed 13 mill. for 2026 when they are settled with Weeco Pharma, then we should be notified. Even though they say they haven't provided any guidance. I believe there is a probability of an upward revision, since at least 8 platforms have the oil in stock. From now and approx. 14 days ahead, Stenocare will have settled with Weeco Pharma. Maybe I shouldn't blink, so I don't miss the news .😶
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti

Vain PDF

68 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 3 päivää sitten
    ·
    Buying up again today
  • 10.7.
    ·
    I only discovered this today. Weeco Pharma has been at the EU's largest cannabis fair for professionals such as pharmacists and dealers. Weeco Astrum10-10 was part of their campaign already at the fair, which may be the reason why it has been possible for Weeco Pharma that so many doctors, in such a short time, have become aware of the oil. https://weeco.com/en/2026/02/13/weeco-will-be-present-at-the-icbc-in-berlin-on-april-13th-and-15th/
    19 t sitten
    ·
    It's also nothing new that there is risk in investing in stocks, and that applies to all stocks, there are no safe stocks, see what has happened with Novo Nordisk, just to give an example of a stock that was considered a safe investment. The only thing I am impatient about is to find out how much Stenocare has earned in Q2, in Germany. Tomorrow it will be 14 days since Q2 closed, and since both pharmacies and the various distributors have been digitized in Germany, Weeco Pharma must soon have finished calculating what Stenocare has earned in Germany. Regardless of the amount's size, it is much more than TS and PJ have announced, since they have stated that there will be 0 kr. in earnings from Germany in 2026.
  • 6.7.
    ·
    A little statistics while we wait for Weeco to get signed with Stenocare. In 2025, more than 6,900 liters of cannabis oils and extracts were sold, and it is expected that this will be increasing in 2026. When I have this converted to 30 ml bottles, with the help of AI, it amounts to 230,000 bottles in 2025. Bearing in mind that the subsidy is taken from flowers and vaporizers, https://www.insight-health.de/deu_en/our-solututions/specialty-therapeutics/medical-cannabis.html
    9.7.
    Ok
  • 6.7.
    ·
    This is falling and falling, it's certainly a hopeless case.
    9.7.
    ·
    10 k in turnover today, is it a sinking ship? Is it just a matter of getting out before the ship sinks?
  • 3.7.
    ·
    STENOCARE completes the integration of CannGros ApS Fri, 3. July 2026 19:37 CETReport this content STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DANMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) is pleased to announce that the integration of CannGros ApS, which was acquired in November 2025, has now been successfully completed by the end of June 2026. The integration of CannGros ApS has been completed as planned with several successful import, repackaging and sales processes, the company merger concluded and process optimizations implemented to reduce both costs and delivery time. https://news.cision.com/stenocare/r/stenocare-completes-integration-of-canngros-aps,c4371090
    5.7. · Muokattu
    ·
    I'm not thinking that far ahead with this stock. I take one quarter at a time..management expects 0 kr. in sales from Germany for the entire 2026. See previous link. There will be revenue from Germany, the question is how much, and if it turns out that management can see that they will exceed 13 mill. for 2026 when they are settled with Weeco Pharma, then we should be notified. Even though they say they haven't provided any guidance. I believe there is a probability of an upward revision, since at least 8 platforms have the oil in stock. From now and approx. 14 days ahead, Stenocare will have settled with Weeco Pharma. Maybe I shouldn't blink, so I don't miss the news .😶
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
7.5.
2025 Q4 -tulosraportti
26.2.
2025 Q3 -tulosraportti
22.10.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti

Vain PDF

68 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
7.5.
2025 Q4 -tulosraportti
26.2.
2025 Q3 -tulosraportti
22.10.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 3 päivää sitten
    ·
    Buying up again today
  • 10.7.
    ·
    I only discovered this today. Weeco Pharma has been at the EU's largest cannabis fair for professionals such as pharmacists and dealers. Weeco Astrum10-10 was part of their campaign already at the fair, which may be the reason why it has been possible for Weeco Pharma that so many doctors, in such a short time, have become aware of the oil. https://weeco.com/en/2026/02/13/weeco-will-be-present-at-the-icbc-in-berlin-on-april-13th-and-15th/
    19 t sitten
    ·
    It's also nothing new that there is risk in investing in stocks, and that applies to all stocks, there are no safe stocks, see what has happened with Novo Nordisk, just to give an example of a stock that was considered a safe investment. The only thing I am impatient about is to find out how much Stenocare has earned in Q2, in Germany. Tomorrow it will be 14 days since Q2 closed, and since both pharmacies and the various distributors have been digitized in Germany, Weeco Pharma must soon have finished calculating what Stenocare has earned in Germany. Regardless of the amount's size, it is much more than TS and PJ have announced, since they have stated that there will be 0 kr. in earnings from Germany in 2026.
  • 6.7.
    ·
    A little statistics while we wait for Weeco to get signed with Stenocare. In 2025, more than 6,900 liters of cannabis oils and extracts were sold, and it is expected that this will be increasing in 2026. When I have this converted to 30 ml bottles, with the help of AI, it amounts to 230,000 bottles in 2025. Bearing in mind that the subsidy is taken from flowers and vaporizers, https://www.insight-health.de/deu_en/our-solututions/specialty-therapeutics/medical-cannabis.html
    9.7.
    Ok
  • 6.7.
    ·
    This is falling and falling, it's certainly a hopeless case.
    9.7.
    ·
    10 k in turnover today, is it a sinking ship? Is it just a matter of getting out before the ship sinks?
  • 3.7.
    ·
    STENOCARE completes the integration of CannGros ApS Fri, 3. July 2026 19:37 CETReport this content STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DANMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) is pleased to announce that the integration of CannGros ApS, which was acquired in November 2025, has now been successfully completed by the end of June 2026. The integration of CannGros ApS has been completed as planned with several successful import, repackaging and sales processes, the company merger concluded and process optimizations implemented to reduce both costs and delivery time. https://news.cision.com/stenocare/r/stenocare-completes-integration-of-canngros-aps,c4371090
    5.7. · Muokattu
    ·
    I'm not thinking that far ahead with this stock. I take one quarter at a time..management expects 0 kr. in sales from Germany for the entire 2026. See previous link. There will be revenue from Germany, the question is how much, and if it turns out that management can see that they will exceed 13 mill. for 2026 when they are settled with Weeco Pharma, then we should be notified. Even though they say they haven't provided any guidance. I believe there is a probability of an upward revision, since at least 8 platforms have the oil in stock. From now and approx. 14 days ahead, Stenocare will have settled with Weeco Pharma. Maybe I shouldn't blink, so I don't miss the news .😶
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt